INJIZIERBARE BOTULINUMTOXINFORMULIERUNGEN

Patent europeic · EP2379104 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2379104
Numer da la dumonda
EP09837072
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
28-12-2009
Publitgà
26-10-2011
Concedì
28-02-2018
La protecziun finescha il pli tard
27-12-2029
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
A61K 39/08 (2006.01)
A61K 8/64 (2006.01)
A61Q 19/08 (2006.01)
Prioritad
US 142063 P 31.12.2008
Dumonda PCT
PCT/US2009/069576 28.12.2009
Publicaziun PCT
WO2010/078242 08.07.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 01-01-2023

    Midada

    Published in Swissreg on 01.01.2023

  5. 28-02-2018

    Concedì

    Published in Swissreg on 28.02.2018

  6. 28-02-2018

    Represchentant inscrit

    Representative
    VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern

    Published in Swissreg on 28.02.2018

Partidas

Possessur

Revance Therapeutics, Inc.

7555 Gateway Boulevard, Newark, CA 94560, US

Represchentant

VENI GmbH

Villa de Meuron Buristrasse 21, 3006 Bern

Inventur

RUEGG, Curtis, L.

Redwood City CA 94062, US

STONE, Hongran, F.

Menlo Park CA 94025, US

WAUGH, Jacob, M.

San Francisco CA 94105, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.